SKI Market

A+| A| A-|

Indian Indices

Sensex

78,387.81 276.57
( 0.35%)

Global Indices

Nasdaq

48,485.12 -71.88
(-0.15%)

Dow Jones

7,044.29 55.91
(0.80%)

Hang Seng

58,133.63 256.24
(0.44%)

Nikkei 225

10,572.50 -36.56
(-0.34%)

Forex

USD-INR

93.24 -0.60
(-0.63%)

EUR-INR

109.88 0.00
(0.00%)

GBP-INR

126.32 0.15
(0.12%)

JPY-INR

0.59 0.00
(-0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

37.8863463

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

72.11

1778.76

EPS(TTM)

Face Value()

Div & Yield %

5.97

0.09

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	156.45	164.07	144.00	123.55	122.46	69.48
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	156.45	164.07	144.00	123.55	122.46	69.48
Other Income	3.91	1.75	1.94	0.94	0.75	1.02
Stock Adjustments	2.85	5.29	0.93	0.17	2.23	0.65
Total Income	163.21	171.11	146.87	124.66	125.44	71.15
EXPENDITURE :
Raw Materials	79.34	85.33	74.61	61.64	57.58	36.75
Power & Fuel Cost	9.83	10.24	8.98	6.67	4.10	3.53
Employee Cost	26.38	23.71	18.21	14.24	11.08	9.07
Other Manufacturing Expenses	3.76	4.10	3.44	2.96	3.77	1.36
Selling & Administrative Expenses	13.44	10.75	9.21	6.42	5.66	8.40
Miscellaneous Expenses	1.12	0.95	0.96	0.52	1.05	0.15
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	133.88	135.07	115.42	92.46	83.23	59.25
Operating Profit	29.34	36.03	31.47	32.21	42.20	11.90
Interest	0.80	1.17	0.75	0.87	1.33	1.91
Gross Profit	28.54	34.86	30.72	31.34	40.87	9.99
Depreciation	4.17	3.33	2.60	2.37	2.10	1.75
Profit Before Tax	24.37	31.53	28.12	28.97	38.77	8.24
Tax	5.97	7.76	7.18	7.35	9.86	1.85
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.12	0.11	-0.09	-0.07	0.13	0.19
Reported Net Profit	18.27	23.66	21.02	21.68	28.77	6.20
Extraordinary Items	0.00	0.00	0.00	0.00	-0.24	0.46
Adjusted Net Profit	18.27	23.66	21.02	21.68	29.01	5.74
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	111.18	89.00	69.22	48.77	20.83	14.62
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.65	1.49	1.24	1.24	0.83	0.00
P & L Balance carried down	127.80	111.18	89.00	69.22	48.77	20.83
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	20.00	20.00	18.00	15.00	15.00	10.00
Dividend Per Share(Rs)	2.00	2.00	1.80	1.50	1.50	1.00
Earnings Per Share-Unit Curr	22.11	28.64	25.44	26.24	34.82	7.50
Earnings Per Share(Adj)-Unit Curr	4.42	5.73	5.09	5.25	6.96	1.50
Book Value-Unit Curr	175.63	155.43	128.38	104.36	79.65	45.76
Book Value(Adj)-Unit Curr	35.13	31.09	25.68	20.87	15.93	9.15

78,387.81 276.57 ( 0.35%)

48,485.12 -71.88 (-0.15%)

7,044.29 55.91 (0.80%)

58,133.63 256.24 (0.44%)

10,572.50 -36.56 (-0.34%)

93.24 -0.60 (-0.63%)

109.88 0.00 (0.00%)

126.32 0.15 (0.12%)

0.59 0.00 (-0.22%)